BLACKROCK HEALTH SCIENCS TR's ticker is BMEZ and the CUSIP is 09260E105. A total of 50 filers reported holding BLACKROCK HEALTH SCIENCS TR in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $1,014,000 | – | 42,500 | – | 0.34% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EPIQ PARTNERS, LLC | 169,250 | $4,451,000 | 2.55% |
| Cornerstone Advisors, LLC | 459,157 | $12,076,000 | 1.06% |
| Matisse Capital | 250,000 | $6,574,000 | 0.95% |
| TRU INDEPENDENCE ASSET MANAGEMENT 2, LLC | 45,356 | $1,193,000 | 0.94% |
| 1607 Capital Partners, LLC | 423,925 | $11,149,000 | 0.54% |
| Thomas J. Herzfeld Advisors, Inc. | 33,722 | $887,000 | 0.40% |
| KAVAR CAPITAL PARTNERS GROUP, LLC | 39,750 | $1,045,000 | 0.28% |
| Stockman Wealth Management, Inc. | 20,296 | $534,000 | 0.15% |
| Karpus Management, Inc. | 186,631 | $4,908,000 | 0.15% |
| CITY OF LONDON INVESTMENT MANAGEMENT CO LTD | 100,211 | $2,631,000 | 0.14% |